Leukemia Home > Gleevec and Prostate Cancer

Healthcare providers can prescribe Gleevec® (imatinib mesylate) for cancers of the blood, bone marrow, skin, and digestive tract. These include:
  • Leukemia and related cancers of the blood and bone marrow
  • A rare type of skin cancer known as dermatofibrosarcoma protuberans
  • A rare type of gastrointestinal cancer called gastrointestinal stromal tumors (GIST).
Studies have examined using Gleevec to treat other types of cancer, including thyroid, ovarian, and prostate cancer. Unfortunately, based on the study results, it appears to be ineffective for ovarian and prostate cancer.
(Click Gleevec Uses for in-depth information on the conditions this drug is used to treat, when it is recommended, how it works, and more.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.